相似文献
1
Genetic and Immunological Pathogenesis of Atopic Dermatitis.
J Invest Dermatol. 2024 May;144(5):954-968. doi: 10.1016/j.jid.2023.10.019. Epub 2023 Dec 11.
2
Increased loss-of-function filaggrin gene mutation prevalence in atopic dermatitis patients across northern latitudes indicates genetic fitness: A systematic review and meta-analysis.
Exp Dermatol. 2024 Jul;33(7):e15130. doi: 10.1111/exd.15130.
3
Effect of Particulate Matter in Atopic Dermatitis through HDACs and Filaggrin Alteration.
J Microbiol Biotechnol. 2025 Jul 18;35:e2502047. doi: 10.4014/jmb.2502.02047.
4
Frequent oil baths and skin barrier during infancy in the PreventADALL study.
Br J Dermatol. 2024 Jun 20;191(1):49-57. doi: 10.1093/bjd/ljae091.
5
Several Proinflammatory Genes' Variability and Phenotypes of Atopic Dermatitis in Czech Adult AD Patients.
Genes (Basel). 2025 Jun 12;16(6):703. doi: 10.3390/genes16060703.
6
The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.
Clin Rev Allergy Immunol. 2016 Dec;51(3):315-328. doi: 10.1007/s12016-015-8508-5.
7
Temporal relationships between Staphylococcus aureus colonization, filaggrin expression, and pediatric atopic dermatitis.
Allergy. 2024 Jan;79(1):104-115. doi: 10.1111/all.15871. Epub 2023 Aug 31.
8
Phenylalanine amide derivatives promote FLG expression via AHR activation in normal human epidermal keratinocytes.
J Pharmacol Sci. 2025 Sep;159(1):44-53. doi: 10.1016/j.jphs.2025.06.005. Epub 2025 Jun 23.
9
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.
Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080.
10
Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis.
BMJ. 2009 Jul 9;339:b2433. doi: 10.1136/bmj.b2433.
引用本文的文献
1
Vitamin D and Atopic Dermatitis-A Mere Correlation or a Real Supportive Treatment Option?
Nutrients. 2025 Aug 8;17(16):2582. doi: 10.3390/nu17162582.
2
Prevention of Atopic Dermatitis: What Are We Missing?
Allergy Asthma Immunol Res. 2025 Jul;17(4):433-446. doi: 10.4168/aair.2025.17.4.433.
3
Possible Crosstalk and Alterations in Gut Bacteriome and Virome in HIV-1 Infection and the Associated Comorbidities Related to Metabolic Disorder.
Viruses. 2025 Jul 16;17(7):990. doi: 10.3390/v17070990.
4
Anti-Inflammatory Therapies for Atopic Dermatitis: A New Era in Targeted Treatment.
J Clin Med. 2025 Jul 16;14(14):5053. doi: 10.3390/jcm14145053.
5
Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases.
Int J Mol Sci. 2025 Jul 14;26(14):6745. doi: 10.3390/ijms26146745.
6
A genome-wide pleiotropy study between atopic dermatitis and neuropsychiatric disorders.
Hum Genomics. 2025 Jul 25;19(1):86. doi: 10.1186/s40246-025-00801-1.
7
Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review.
J Clin Med. 2025 May 30;14(11):3881. doi: 10.3390/jcm14113881.
8
Regulatory T cells and their role in allergic disease.
Allergy. 2025 Jan;80(1):77-93. doi: 10.1111/all.16326. Epub 2024 Sep 27.
9
Thymic stromal lymphopoietin-activated basophil promotes lung inflammation in mouse atopic march model.
Front Immunol. 2025 May 15;16:1573130. doi: 10.3389/fimmu.2025.1573130. eCollection 2025.
10
Neural stem cell-derived extracellular vesicles alleviate inflammatory responses in a mouse model of atopic dermatitis.
Stem Cells. 2025 Jul 21;43(8). doi: 10.1093/stmcls/sxaf034.
本文引用的文献
1
Hyper IgE Syndromes.
Curr Pediatr Rev. 2024;20(3):253-264. doi: 10.2174/1573396320666230912103124.
2
The role of Janus kinase signaling in the pathology of atopic dermatitis.
J Allergy Clin Immunol. 2023 Dec;152(6):1394-1404. doi: 10.1016/j.jaci.2023.07.010. Epub 2023 Aug 1.
3
Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis.
J Invest Dermatol. 2024 Jan;144(1):53-62.e2. doi: 10.1016/j.jid.2023.06.201. Epub 2023 Jul 22.
4
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis.
J Allergy Clin Immunol. 2023 Oct;152(4):916-926. doi: 10.1016/j.jaci.2023.06.023. Epub 2023 Jul 13.
5
Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study.
Front Med (Lausanne). 2023 Jun 22;10:1174331. doi: 10.3389/fmed.2023.1174331. eCollection 2023.
6
Mendelian randomization indicates that atopic dermatitis contributes to the occurrence of diabetes.
BMC Med Genomics. 2023 Jun 15;16(1):132. doi: 10.1186/s12920-023-01575-y.
7
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
JAMA Dermatol. 2023 Jun 1;159(6):596-605. doi: 10.1001/jamadermatol.2023.0627.
8
Association of atopic dermatitis with conjunctivitis and other ocular surface diseases: A bidirectional two-sample Mendelian randomization study.
J Eur Acad Dermatol Venereol. 2023 Mar 15. doi: 10.1111/jdv.19048.
9
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15.
10
A combination of HLA-DP α and β chain polymorphisms paired with a SNP in the DPB1 3' UTR region, denoting expression levels, are associated with atopic dermatitis.
Front Genet. 2023 Jan 23;14:1004138. doi: 10.3389/fgene.2023.1004138. eCollection 2023.
Zotero 插件